This inventor holds 1 USPTO granted patent. Top assignee: Leibniz-Institut Für Naturstoff-Forschung Und Infektionsbiologie. Active years: 2016.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2016
Title: Mikko Metsae-Ketelae: Innovator in Pharmaceutical Research
Introduction
Mikko Metsae-Ketelae is a notable inventor based in Turku, Finland. He has made significant contributions to the field of pharmaceutical research, particularly in the development of novel compounds for medical applications.
Latest Patents
Mikko holds a patent for Chartreusin analogues. This invention relates to novel Chartreusin analogues of formula (I), pharmaceutical compositions comprising the same, and their use for the treatment of cancer and other diseases. He has 1 patent to his name, showcasing his innovative approach to addressing critical health issues.
Career Highlights
Mikko is affiliated with the Leibniz Institute for Natural Product Research and Infection Biology. His work at this esteemed institution has allowed him to explore various aspects of natural product chemistry and its applications in medicine.
Collaborations
Mikko has collaborated with notable researchers in his field, including Christian Hertweck and Hans-Martin Dahse. These partnerships have enhanced his research and contributed to the advancement of pharmaceutical sciences.
Conclusion
Mikko Metsae-Ketelae is a dedicated inventor whose work in pharmaceutical research is paving the way for innovative treatments. His contributions are vital in the ongoing fight against cancer and other diseases.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile